Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 245

    1.

    Hydrogen Sulfide Scavenges the Cytotoxic Lipid Oxidation Product 4-HNE.

    Schreier SM, Muellner MK, Steinkellner H, Hermann M, Esterbauer H, Exner M, Gmeiner BM, Kapiotis S, Laggner H.

    Neurotox Res. 2009 Aug 13. [Epub ahead of print]PMID: 19680736 [PubMed - as supplied by publisher]Related articles

    2.

    DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia.

    Ganster C, Neesen J, Zehetmayer S, Jäger U, Esterbauer H, Mannhalter C, Kluge B, Fonatsch C.

    Genes Chromosomes Cancer. 2009 Sep;48(9):760-7.PMID: 19484764 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL.

    Muellner MK, Schreier SM, Laggner H, Hermann M, Esterbauer H, Exner M, Gmeiner BM, Kapiotis S.

    Biochem J. 2009 May 13;420(2):277-81.PMID: 19265508 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients.

    Szendroedi J, Anderwald C, Krssak M, Bayerle-Eder M, Esterbauer H, Pfeiler G, Brehm A, Nowotny P, Hofer A, Waldhäusl W, Roden M.

    Diabetes Care. 2009 Feb;32(2):209-14. Epub 2008 Oct 28.PMID: 18957532 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genes.

    Vanura K, Le T, Esterbauer H, Späth F, Porpaczy E, Shehata M, Eigenberger K, Hauswirth A, Skrabs C, Krömer E, Schwarzinger I, Streubel B, Steininger C, Fonatsch C, Stilgenbauer S, Wagner O, Gaiger A, Jäger U.

    Haematologica. 2008 Dec;93(12):1912-6. Epub 2008 Oct 6.PMID: 18838479 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRalpha.

    Baumgartner C, Gleixner KV, Peter B, Ferenc V, Gruze A, Remsing Rix LL, Bennett KL, Samorapoompichit P, Lee FY, Pickl WF, Esterbauer H, Sillaber C, Superti-Furga G, Valent P.

    Exp Hematol. 2008 Oct;36(10):1244-53. Epub 2008 Jul 10.PMID: 18619723 [PubMed - indexed for MEDLINE]Related articles

    7.

    Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens.

    Mayerhofer M, Gleixner KV, Hoelbl A, Florian S, Hoermann G, Aichberger KJ, Bilban M, Esterbauer H, Krauth MT, Sperr WR, Longley JB, Kralovics R, Moriggl R, Zappulla J, Liblau RS, Schwarzinger I, Sexl V, Sillaber C, Valent P.

    J Immunol. 2008 Apr 15;180(8):5466-76.PMID: 18390729 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Prognostic value of T-cell receptor gamma rearrangement in peripheral blood or bone marrow of patients with peripheral T-cell lymphomas.

    Schützinger C, Esterbauer H, Hron G, Skrabs C, Uffmann M, Raderer M, Hauswirth A, Mannhalter C, Dieckmann K, Wagner O, Formanek M, Stift A, Friedl J, Gaiger A, Chott A, Jäger U.

    Leuk Lymphoma. 2008 Feb;49(2):237-46.PMID: 18231909 [PubMed - indexed for MEDLINE]Related articles

    9.

    Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone.

    Wöhrer S, Rabitsch W, Shehata M, Kondo R, Esterbauer H, Streubel B, Sillaber C, Raderer M, Jaeger U, Zielinski C, Valent P.

    Anticancer Res. 2007 Nov-Dec;27(6B):3837-41.PMID: 18225540 [PubMed - indexed for MEDLINE]Related articles

    10.

    Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.

    Haas K, Kundi M, Sperr WR, Esterbauer H, Ludwig WD, Ratei R, Koller E, Gruener H, Sauerland C, Fonatsch C, Valent P, Wieser R.

    Genes Chromosomes Cancer. 2008 Apr;47(4):288-98.PMID: 18181178 [PubMed - indexed for MEDLINE]Related articles

    11.

    Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia.

    Sillaber C, Mayerhofer M, Böhm A, Vales A, Gruze A, Aichberger KJ, Esterbauer H, Pfeilstöcker M, Sperr WR, Pickl WF, Haas OA, Valent P.

    Eur J Clin Invest. 2008 Jan;38(1):43-52.PMID: 18173550 [PubMed - indexed for MEDLINE]Related articles

    12.

    Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib.

    Mayerhofer M, Gleixner KV, Mayerhofer J, Hoermann G, Jaeger E, Aichberger KJ, Ott RG, Greish K, Nakamura H, Derdak S, Samorapoompichit P, Pickl WF, Sexl V, Esterbauer H, Schwarzinger I, Sillaber C, Maeda H, Valent P.

    Blood. 2008 Feb 15;111(4):2200-10. Epub 2007 Nov 16.PMID: 18024796 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.

    Pospisilik JA, Knauf C, Joza N, Benit P, Orthofer M, Cani PD, Ebersberger I, Nakashima T, Sarao R, Neely G, Esterbauer H, Kozlov A, Kahn CR, Kroemer G, Rustin P, Burcelin R, Penninger JM.

    Cell. 2007 Nov 2;131(3):476-91.PMID: 17981116 [PubMed - indexed for MEDLINE]Related articles

    14.

    The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells.

    Laggner H, Hermann M, Esterbauer H, Muellner MK, Exner M, Gmeiner BM, Kapiotis S.

    J Hypertens. 2007 Oct;25(10):2100-4.PMID: 17885553 [PubMed - indexed for MEDLINE]Related articles

    15.

    Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571).

    Agis H, Sperr WR, Herndlhofer S, Semper H, Pirc-Danoewinata H, Haas OA, Mannhalter C, Esterbauer H, Geissler K, Sillaber C, Jäger U, Valent P.

    Ann Oncol. 2007 Nov;18(11):1834-41. Epub 2007 Sep 5.PMID: 17804468 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.

    Aichberger KJ, Herndlhofer S, Agis H, Sperr WR, Esterbauer H, Rabitsch W, Knöbl P, Haas OA, Thalhammer R, Schwarzinger I, Sillaber C, Jäger U, Valent P.

    Eur J Clin Invest. 2007 Oct;37(10):808-13. Epub 2007 Aug 28.PMID: 17727673 [PubMed - indexed for MEDLINE]Related articles

    17.

    Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor.

    Promintzer M, Krebs M, Todoric J, Luger A, Bischof MG, Nowotny P, Wagner O, Esterbauer H, Anderwald C.

    J Clin Endocrinol Metab. 2007 Nov;92(11):4306-12. Epub 2007 Aug 28.PMID: 17726077 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.

    Böhm A, Födinger M, Wimazal F, Haas OA, Mayerhofer M, Sperr WR, Esterbauer H, Valent P.

    J Allergy Clin Immunol. 2007 Jul;120(1):192-9. Epub 2007 Apr 23.PMID: 17451799 [PubMed - indexed for MEDLINE]Related articles

    19.

    Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells.

    Kondo R, Gleixner KV, Mayerhofer M, Vales A, Gruze A, Samorapoompichit P, Greish K, Krauth MT, Aichberger KJ, Pickl WF, Esterbauer H, Sillaber C, Maeda H, Valent P.

    Blood. 2007 Jul 15;110(2):661-9. Epub 2007 Apr 9.PMID: 17420286 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The dietary soy flavonoid genistein abrogates tissue factor induction in endothelial cells induced by the atherogenic oxidized phospholipid oxPAPC.

    Holzer G, Esterbauer H, Kronke G, Exner M, Kopp CW, Leitinger N, Wagner O, Gmeiner BM, Kapiotis S.

    Thromb Res. 2007;120(1):71-9. Epub 2006 Oct 2.PMID: 17014893 [PubMed - indexed for MEDLINE]Related articles

    21.

    The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells.

    Aichberger KJ, Mayerhofer M, Vales A, Krauth MT, Gleixner KV, Bilban M, Esterbauer H, Sonneck K, Florian S, Derdak S, Pickl WF, Agis H, Falus A, Sillaber C, Valent P.

    Blood. 2006 Nov 15;108(10):3538-47. Epub 2006 Jul 18.PMID: 16849647 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Carbon monoxide orchestrates a protective response through PPARgamma.

    Bilban M, Bach FH, Otterbein SL, Ifedigbo E, d'Avila JC, Esterbauer H, Chin BY, Usheva A, Robson SC, Wagner O, Otterbein LE.

    Immunity. 2006 May;24(5):601-10.PMID: 16713977 [PubMed - indexed for MEDLINE]Related articles

    23.

    Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modification.

    Kapiotis S, Jirovetz L, Hermann M, Laggner H, Exner M, Esterbauer H, Gmeiner BM.

    Biochimie. 2006 Jul;88(7):785-91. Epub 2006 Feb 2.PMID: 16488068 [PubMed - indexed for MEDLINE]Related articles

    24.

    Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib.

    Florian S, Esterbauer H, Binder T, Müllauer L, Haas OA, Sperr WR, Sillaber C, Valent P.

    Leuk Res. 2006 Sep;30(9):1201-5. Epub 2006 Jan 6.PMID: 16406018 [PubMed - indexed for MEDLINE]Related articles

    25.

    Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds.

    Aichberger KJ, Mayerhofer M, Krauth MT, Vales A, Kondo R, Derdak S, Pickl WF, Selzer E, Deininger M, Druker BJ, Sillaber C, Esterbauer H, Valent P.

    Cancer Res. 2005 Oct 15;65(20):9436-44.PMID: 16230407 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells.

    Mayerhofer M, Aichberger KJ, Florian S, Krauth MT, Hauswirth AW, Derdak S, Sperr WR, Esterbauer H, Wagner O, Marosi C, Pickl WF, Deininger M, Weisberg E, Druker BJ, Griffin JD, Sillaber C, Valent P.

    FASEB J. 2005 Jun;19(8):960-2. Epub 2005 Mar 22.PMID: 15784722 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2.

    Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP, Esterbauer H, Hauser-Kronberger C, Frischauf AM, Aberger F.

    Cancer Res. 2004 Nov 1;64(21):7724-31.PMID: 15520176 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Haptoglobin phenotype and gestational diabetes.

    Mustafa S, Vukovich T, Prikoszovich T, Winzer C, Schneider B, Esterbauer H, Wagner O, Kautzky-Willer A.

    Diabetes Care. 2004 Sep;27(9):2103-7.PMID: 15333469 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with hypertension in middle-aged men.

    Oberkofler H, Hölzl B, Esterbauer H, Xie M, Iglseder B, Krempler F, Paulweber B, Patsch W.

    Hypertension. 2003 Feb;41(2):368-72.PMID: 12574109 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.

    Krempler F, Esterbauer H, Weitgasser R, Ebenbichler C, Patsch JR, Miller K, Xie M, Linnemayr V, Oberkofler H, Patsch W.

    Diabetes. 2002 Nov;51(11):3331-5.PMID: 12401727 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Sterol regulatory element binding proteins: relationship of adipose tissue gene expression with obesity in humans.

    Oberkofler H, Fukushima N, Esterbauer H, Krempler F, Patsch W.

    Biochim Biophys Acta. 2002 May 3;1575(1-3):75-81.PMID: 12020821 [PubMed - indexed for MEDLINE]Related articles

    32.

    Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women.

    Esterbauer H, Oberkofler H, Linnemayr V, Iglseder B, Hedegger M, Wolfsgruber P, Paulweber B, Fastner G, Krempler F, Patsch W.

    Diabetes. 2002 Apr;51(4):1281-6.PMID: 11916956 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 recruitment regulates PPAR subtype specificity.

    Oberkofler H, Esterbauer H, Linnemayr V, Strosberg AD, Krempler F, Patsch W.

    J Biol Chem. 2002 May 10;277(19):16750-7. Epub 2002 Mar 1.PMID: 11875072 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans.

    Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, Ladurner G, Hell E, Strosberg AD, Patsch JR, Krempler F, Patsch W.

    Nat Genet. 2001 Jun;28(2):178-83.PMID: 11381268 [PubMed - indexed for MEDLINE]Related articles

    35.

    Ultrastructural analysis of HNE-treated Saccharomyces cerevisiae cells reveals fragmentation of the vacuole and an accumulation of lipids in the cytosol.

    Wonisch W, Zellnig G, Kohlwein SD, Schaur RJ, Bilinski T, Tatzber F, Esterbauer H.

    Cell Biochem Funct. 2001 Mar;19(1):59-64. No abstract available. PMID: 11223872 [PubMed - indexed for MEDLINE]Related articles

    36.

    Postprandial lipemia and coronary risk.

    Patsch W, Esterbauer H, Föger B, Patsch JR.

    Curr Atheroscler Rep. 2000 May;2(3):232-42. Review.PMID: 11122749 [PubMed - indexed for MEDLINE]Related articles

    37.

    UCP3 gene expression does not correlate with muscle oxidation rates in troglitazone-treated Zucker fatty rats.

    Oberkofler H, Neschen S, Esterbauer H, Waldhäusl W, Patsch W, Fürnsinn C.

    Biochim Biophys Acta. 2000 Dec 15;1517(1):113-8.PMID: 11118623 [PubMed - indexed for MEDLINE]Related articles

    38.

    The uncoupling protein-3 gene is transcribed from tissue-specific promoters in humans but not in rodents.

    Esterbauer H, Oberkofler H, Krempler F, Strosberg AD, Patsch W.

    J Biol Chem. 2000 Nov 17;275(46):36394-9.PMID: 10958796 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    The Gln27Glu polymorphism in the beta2-adrenergic receptor gene is not associated with morbid obesity in Austrian women.

    Oberkofler H, Esterbauer H, Hell E, Krempler F, Patsch W.

    Int J Obes Relat Metab Disord. 2000 Mar;24(3):388-90.PMID: 10757636 [PubMed - indexed for MEDLINE]Related articles

    40.

    Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors.

    Krempler F, Breban D, Oberkofler H, Esterbauer H, Hell E, Paulweber B, Patsch W.

    Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):443-9.PMID: 10669642 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression.

    Esterbauer H, Oberkofler H, Krempler F, Patsch W.

    Genomics. 1999 Nov 15;62(1):98-102.PMID: 10585775 [PubMed - indexed for MEDLINE]Related articles

    42.

    The complement system: a pathway linking host defence and adipocyte biology.

    Esterbauer H, Krempler F, Oberkofler H, Patsch W.

    Eur J Clin Invest. 1999 Aug;29(8):653-6. Review. No abstract available. PMID: 10457146 [PubMed - indexed for MEDLINE]Related articles

    43.

    Uncoupling protein-3 gene expression: reduced skeletal muscle mRNA in obese humans during pronounced weight loss.

    Esterbauer H, Oberkofler H, Dallinger G, Breban D, Hell E, Krempler F, Patsch W.

    Diabetologia. 1999 Mar;42(3):302-9.PMID: 10096782 [PubMed - indexed for MEDLINE]Related articles

    44.

    Allele-specific differences in apolipoprotein C-III mRNA expression in human liver.

    Esterbauer H, Hell E, Krempler F, Patsch W.

    Clin Chem. 1999 Mar;45(3):331-9.PMID: 10053033 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    A sensitive chemiluminescence method to measure the lipoxygenase catalyzed oxygenation of complex substrates.

    Kratky D, Lass A, Abuja PM, Esterbauer H, Kühn H.

    Biochim Biophys Acta. 1999 Jan 29;1437(1):13-22.PMID: 9931410 [PubMed - indexed for MEDLINE]Related articles

    46.

    The cardiac acetylcholine-activated, inwardly rectifying K+-channel subunit GIRK1 gives rise to an inward current induced by free oxygen radicals.

    Jeglitsch G, Ramos P, Encabo A, Tritthart HA, Esterbauer H, Groschner K, Schreibmayer W.

    Free Radic Biol Med. 1999 Feb;26(3-4):253-9.PMID: 9895214 [PubMed - indexed for MEDLINE]Related articles

    47.

    Treatment of the budding yeast Saccharomyces cerevisiae with the lipid peroxidation product 4-HNE provokes a temporary cell cycle arrest in G1 phase.

    Wonisch W, Kohlwein SD, Schaur J, Tatzber F, Guttenberger H, Zarkovic N, Winkler R, Esterbauer H.

    Free Radic Biol Med. 1998 Oct;25(6):682-7.PMID: 9801068 [PubMed - indexed for MEDLINE]Related articles

    48.

    Uncoupling protein-2 gene: reduced mRNA expression in intraperitoneal adipose tissue of obese humans.

    Oberkofler H, Liu YM, Esterbauer H, Hell E, Krempler F, Patsch W.

    Diabetologia. 1998 Aug;41(8):940-6.PMID: 9726597 [PubMed - indexed for MEDLINE]Related articles

    49.

    Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in thymocytes as an effective secondary antioxidative defense mechanism.

    Siems WG, Pimenov AM, Esterbauer H, Grune T.

    J Biochem. 1998 Mar;123(3):534-9.PMID: 9538239 [PubMed - indexed for MEDLINE]Related articles

    50.

    Copper can promote oxidation of LDL by markedly different mechanisms.

    Ziouzenkova O, Sevanian A, Abuja PM, Ramos P, Esterbauer H.

    Free Radic Biol Med. 1998 Mar 1;24(4):607-23.PMID: 9559873 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...